Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Palliative Care × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Urinary Bladder Neoplasms 1 Stress Disorders, Post-Traumatic 1 Prostatic Neoplasms 1 Penile Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Malignant Solid Neoplasm 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Kidney Neoplasms 1 Inflammatory Breast Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Agnosia 1

Interventions

Specimen Handling 32 Biopsy 30 Magnetic Resonance Spectroscopy 21 pembrolizumab 18 Nivolumab 12 trastuzumab deruxtecan 9 Paclitaxel 9 Pemetrexed 8 Cisplatin 8 Carboplatin 8 Taxes 7 Leucovorin 6 Irinotecan 6 Ipilimumab 6 Gemcitabine 6 Fulvestrant 6 Fluorouracil 6 Cetuximab 6 Capecitabine 6 130-nm albumin-bound paclitaxel 6 X-Rays 5 Radiosurgery 5 Oxaliplatin 5 Cyclophosphamide 5 abemaciclib 4 Trastuzumab 4 Drug Therapy 4 Doxorubicin 4 tislelizumab 3 talazoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07195513 2026-03-10

PRO-CONNECT

Dartmouth-Hitchcock Medical Center

Phase NA Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡